Louise Rodino-Klapac - Head of R&D, CSO at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Head of R&D, CSO
Stock Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Louise Rodino-Klapac since 10/2/2023

Holdings reported by Louise Rodino-Klapac for Sarepta Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 72.1K $11.9M $164.64 Jun 24, 2024 Direct
Performance Stock Units 0 $0 $163.23 Jun 21, 2024 Direct Common Stock
Stock Option (right to buy) 12.5K Mar 1, 2024 Direct Common Stock

Transactions reported by Louise Rodino-Klapac for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.